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REVIEW 
The POU domain: versatility 
in transcriptional regulation by a flexible 
two-in-one DNA-binding domain 
Winship Herr 1 and Michele A. Cleary 1'2 
~Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724 USA; 2Department of Molecular Genetics and 
Microbiology, State University of New York at Stony Brook, Stony Brook New York 11794 USA 
The DNA-binding domains of eukaryotic transcriptional 
activators play a key role in selective promoter activa- 
tion by tethering activation domains to the appropriate 
promoters and by coordinating the assembly of specific 
sets of transcription factors on these promoters. How an 
activator binds DNA and interacts with other transcrip- 
tional regulators is profoundly influenced by the struc- 
ture of its DNA-binding domain. For example, activators 
that carry a basic-leucine zipper DNA-binding domain 
are well suited to establish intricate cross-regulatory net- 
works with other family members because they bind 
DNA as dimers and display differing abilities to form 
homodimers and heterodimers with other leucine zipper 
proteins (for review, see Alber 1992). 
Another DNA-binding domain whose structure has an 
impact on the transcriptional regulatory properties of ac- 
tivators is the POU domain. The POU (for Pit, Oct, 
UNC) domain was discovered as a large region of se- 
quence similarity among three mammalian transcrip- 
tion factors, Pit-l, Oct- 1, and Oct-2, and a nematode cell 
lineage gene product, UNC-86 (Herr et al. 1988). POU 
domains have since been identified in over 20 other 
metazoan proteins, although they have yet to be identi- 
fied in fungal or plant proteins. Studies of these POU 
domain-containing proteins have implicated them in the 
regulation of celt-specific patterns of transcription and 
development, properties that have been described previ- 
ously in reviews by Rosenfeld (1991), Ruvkun and 
Finney (1991), and Verrijzer and van der Vliet (t993). 
The structure of the POU domain is unique among 
DNA-binding domains because it contains two structur- 
ally independent domains that cooperate functionally as 
a DNA-binding unit. In this review we focus on the re- 
lationship between the structure of the POU domain and 
the transcriptional regulatory properties of POU pro- 
teins. We first describe the structure of the Oct-1 POU 
domain and then discuss how the structural f exibility of 
the bipartite POU domain leads to flexible interactions 
with DNA and other proteins and, thus, functional ver- 
satility in transcriptional regulation. 
The POU domain 
Figure 1 shows a simple schematic of the POU domain. 
Two segments of the POU-domain sequence are highly 
conserved, an -75-amino-acid amino-terminal POU- 
specific (POUs) domain and a 60-amino-acid carboxy-ter- 
minal homeo (POUrs) domain (Herr et al. 1988). Joining 
these two segments is a hypervariable linker segment 
that can vary from 15 to 56 amino acids in length (Herr 
et al. 1988; Greenstein et al. 1994). 
Contrary to what the name might suggest, the POU 
domain is not a single structural domain; indeed, the 
POUs and POU H segments form separate structurally 
independent domains (Botfield et al. 1992). The POUs 
and POUH domains are, however, always found together 
and have therefore coevolved. Thus, the POU domain, 
albeit not a single structural domain, is a functional unit, 
and therefore the term "POU domain" remains useful. 
Soon after its discovery, the nature of the POU-domain 
structure was surmised from mutational studies, which 
indicated that the POUs and POUH regions form two 
DNA-binding subsegments and that the hypervariable 
region forms a flexible linker (Sturm and Herr 1988; In- 
graham et al. 1990; Kristie and Sharp 1990; Verrijzer et 
al. 1990). Subsequent s ructural and biochemical studies 
showed that both the POU s and POUR segments have 
independent structures (Botfield et al. 19921 and make 
sequence-specific contacts with DNA (Aurora and Herr 
1992; Verrijzer et al. 1992). These conclusions have been 
confirmed by X-ray crystallographic studies of the Oct-1 
POU domain bound to a natural high-affinity binding 
site, the octamer sequence ATGCAAAT in the histone 
H2B promoter (Klemm et al. 1994). 
L INKER 
t POUs POU. 
Figure 1. Linear representation f the POU domain showing 
the relative positions of the POUs, POUH, and linker segments. 
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Figure 2 shows an illustration, adapted from Klemm et 
al. (1994), of the Oct-1 POU domain bound to the histone 
H2B octamer site. The Oct-1 POUs (red) and POUH (blue) 
domains both lie in the major groove, but on opposite 
sides of the DNA, with the POUs domain contacting the 
5' ATGC segment and the POU H domain contacting to 
the 3' AAAT segment of the octamer sequence. Impor- 
tantly, when bound to this site, the two POU subdo- 
mains make no intersubunit contacts--instead, they ap- 
pear to be held together solely by the linker (gold), whose 
structure, if any, was not revealed by the crystallo- 
graphic study (Klemm et al. 1994). 
Figure 3 shows a comparison of 19 POU-domain se- 
quences, indicating the position of a-helices in the POUs 
and POUIj domains and residues that are invariant 
among all available POU-domain sequences. Unlike the 
POUs domain, which is so far unique to POU proteins, 
homeo domains are found in many other DNA-binding 
proteins. Nonetheless, homeo domains found in POLl 
proteins form a unique subfamily of more closely related 
homeo-domain sequences (Herr et al. 1988; Bfirglin 
1994; see Fig. 3). For this reason, they are referred to as 
POUI_I-type homeo domains. 
The POUs and POU H domains  both conta in  
he l ix - tu rn -he l ix  mot i fs  
The POU H domain is nearly identical in structure to 
other homeo domains (Klemm et al. 1994; Sivaraja et al. 
1994), whereas the Oct-1 POU s domain is much more 
similar in structure to the bacteriophage h and 434 re- 
pressor, and 434 Cro DNA-binding domains (Assa-Munt 
et al. 1993; Dekker et al. 1993). Figure 4 shows similar 
perspectives of the Oct-1 POUs and POU H domains 
bound to DNA, il lustrating the similarities and differ- 
ences between these two POU-domain DNA-binding 
structures. Both DNA-binding domains contain a hel ix- 
turn-hel ix (HTH) motif (yellow barrels in Fig. 4), a struc- 
ture common to a broad class of DNA-binding domains 
(for review, see Pabo and Sauer 1992). This structure con- 
sists of two approximately perpendicular a-helices 
(POUs and POUIj helices a2 and a3 in Fig. 3) connected 
by a short turn; the second of the two helices (a3, the 
"DNA-recognition helix") makes many contacts with 
bases in the DNA. HTH motifs are not stable on their 
Figure 2. Schematic of the Oct-1 POU domain bound to the 
histone H2B octamer sequence, adapted from the X-ray cocrys- 
tal structure described by Klemm et al. (1994). The POUs do- 
main is shown in red, the POUH domain is shown in blue, and 
the linker segment is shown in gold, with broken lines to indi- 
cate its unknown structure. The individual POUs- and POUH- 
domain helices are numbered as in Fig. 3. (NI Amino terminus; 
(C1 carboxyl terminus. 
own but gain stability through interactions with other 
protein segments, which can vary greatly in structure. 
As shown in Figure 4, in the POUs domain, as in the 
bacteriophage h repressor DNA-binding domain, two a
helices (al and a4) stabilize the HTH motif, whereas in 
the POU H domain, as in other homeo domains, a single 
a-helix (al) stabilizes the HTH motif. 
POUs-domain  structure 
Although the POUs-domain structure is very similar to 
that of the h and 434 bacteriophage proteins, there are 
Figure 3. Amino acid sequence alignment of the POUs (A), linker (B), and POUH (C) segments of Oct-1 and 18 other POU domains. 
The sequences li ted were chosen because they represent the different types of POU domains that have been identified. Sequences not 
included in the comparison are very similar to ones that are shown: For example, Brn-1 and Brn-4 are similar to Brn-2 (Hara et al. 1992), 
Bm-3.2/Brn-3b and Brn-3.1/Brn-3c are similar to Brn-3.0/Brn-3a (Gerrero t al. 1993; Theil et al. 1993), and pdm-1/dPOU19 is similar 
to miti-mere/pdm-2/dPOU28 (Billin et al. 1991; Lloyd and Sakonju 1991). Dots represent amino acids identical to those found in 
Oct-i; dashes indicate gaps introduced to maximize similarity. Invariant residues are listed below the POUs and POU. domain 
sequence comparisons in boldface type, and the positions of the c~-helices are indicated by boxes. The POU-domain sequences are from 
the following sources: Oct-1 (Sturm et al. 1988); Oct-2 (Clerc et al. 1988; M/iller et al. 1988; Scheidereit e  al. 1988); Skn-1 (Andersen 
et al. 1993a); miti-mere/pdm-2/dPOU28 (Billin et al. 1991; Lloyd and Sakonju 1991; Bhat nd Schedl 1994); CEH-18 (Greenstein etal. 
1994); SCIP (Monuki et al. 1989); CEH-6 {B/irglin et al. 1989); drifter/Cfla (Johnson and Hirsh 1990; Anderson et al. 1995); Brn-2 (Hara 
et al. 1992); Oct-3/Oct-4 (Okamoto et al. 1990, Rosner et al. 1990; Sch61er et al. 1990); zfpou2 (Takeda et al. 1994); xl p25, xl p60, and 
xl p91 (Hinkley et al. 1992); Pit-1/GHF-1 (Bodner et al. 1988; Ingraham et al. 1988); tI-POU (Treacy et al. 1992); Brn-3.0/Brn-3a (Gerrero 
et al. 1993); UNC-86 (Finney et al. 1988); Brn-5 (Andersen et al. 1993b). 
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Figure 4. Similar perspectives of the 
Oct-1 POUs (A) and POUH (B) domains 
bound to the histone H2B octamer se- 
quence (Klemm et al. 1994), with the HTH 
motifs shown in yellow. In relation to Fig. 
2, the POUs domain is shown viewed from 
the bottom with the top in A facing left in 
Fig. 2, and the POUrt domain is shown 
viewed from the top with the top in B fac- 
ing right in Fig. 2. 
differences. One significant difference is in the segment 
of greatest similarity among HTH-containing proteins, 
the HTH structure itself. Figure 5 shows a view of the 
Oct-1 POUs-domain HTH structure, with broken lines 
indicating where the h repressor HTH structure would 
lie. In the Oct-1 POU s HTH structure, the first a-helix 
{a2} is one turn longer than the corresponding h repressor 
helix, and the linker or "turn" connecting the two HTH 
a-helices is also longer, maintaining the same relative 
positions of the two HTH a-helices in these proteins 
{Assa-Munt et al. 1993; Dekker et al. 1993). The differ- 
ence in HTH structure xplains why, unlike in the case 
of the homeo domain, where the similarity to HTH-con- 
taining DNA-binding domains was deduced by sequence 
comparison before the structure was known {Laughon 
and Scott 1984; Shepherd et al. 1984), the similarity of 
the POUs domain to an HTH-containing DNA-binding 
domain was revealed only after its structure was deter- 
mined (Assa-Munt et al. 1993; Dekker et al. 1993). 
Because the relative positions of the two HTH a-heli- 
ces in the POUs and bacteriophage DNA-binding do- 
mains are the same, the precise positions of residues im- 
portant for DNA binding {e.g., the circled amino acids in 
Fig. 5} are maintained. Impressively, two of these resi- 
dues and their DNA interactions are the same: In both 
types of DNA-binding domains, the first amino acid of 
each a-helix is a glutamine residue (see Fig. 3), and these 
residues are superimposed when the two structures are 
aligned {see Fig. 5){Assa-Munt et al. 1993). In the bacte- 
riophage IPabo et al. 1990) and Oct-1 POUs {Klemm et al. 
1994) DNA-binding domains, the two glutamines make 
identical coordinated interactions with the phosphate 
backbone and an adenine base in their DNA-binding 
sites (the first A in the ATGCAAAT octamer sequence). 
Mutagenesis tudies have shown that this coordinated 
interaction is important for DNA-sequence recognition 
by the bacteriophage and POU proteins (Wharton and 
Ptashne 1987; Li et al. 1993; Botfield et al. 1994; Jancso 
et al. 1994; Cleary and Herr 1995). 
In the Oct-1 POUs domain and the 434 repressor and 
Cro proteins, there is an identical extended coordinated 
interaction among amino acid side chains involving the 
two glutamines and two additional amino acids, an argi- 
nine and a glutamic acid (residues 20 and 51 in Fig. 3) 
(Klemm et al. 1994). Other than this surprising identity, 
there is little sequence similarity between the POUs do- 
main and the bacteriophage proteins. Thus, with only a 
low level of sequence similarity, an impressive level of 
structural and functional similarity between human and 
bacteriophage DNA-binding proteins is generated, lead- 
ing to similar intramolecular and intermolecular (pro- 
tein to DNA} contacts. This extraordinary similarity 
suggests that, because of its effectiveness for DNA bind- 
ing--and possibly, as described below, for interaction 
with other proteins--this structure has been either 
maintained or derived more than once during evolution. 
Figure 5. Comparison of the Oct-1 POU s and h repressor 
DNA-binding domain HTH motifs. Where the h repressor HTH 
structure differs from the POUs HTH structure, the k repressor 
structure is shown with broken lines. The circled residues how 
the position of the Oct-1 amino acids Q27, Q44, and R49 {refer 
to Fig. 3}. The helices are numbered 2 and 3 as in Figs. 2 and 3. 
(N} Amino terminus; {C) carboxyl terminus. 
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A POUs positive control mutation 
The similarity between the POUs and h repressor DNA- 
binding domains extends beyond how they bind to DNA. 
In h repressor there are mutations, referred to as positive 
control (pc) mutations, that affect its ability to activate 
transcription of its own gene but have little effect on its 
ability to bind DNA or repress transcription (Guarente t 
al. 1982; Hochschild et al. 1983). These pc mutations lie 
on either the exposed surface of a-helix 2 or the turn 
between a-helices 2 and 3 of the h repressor HTH struc- 
ture and affect direct interactions with RNA polymerase 
rather than with DNA (Hochschild et al. 1983; Hawley 
and McClure 1983; Li et al. 1994). 
A pc-type mutation also exists in the POUs domain of 
the human pituitary factor Pit-1. Pit-1 (Ingraham et al. 
1988), also called GHF-1 (Bodner et al. 1988), controls 
transcription of pituitary-specific genes, including the 
growth hormone and prolactin genes (see Rosenfeld 
1991). Although this human Pit-1 mutant binds DNA 
well, it fails to activate transcription of the growth hor- 
mone gene, thus displaying apc phenotype and probably 
causing the human dwarfism associated with this muta- 
tion (Pffiffle et al. 1992). In parallel with the h repressor 
pc mutations, the human Pit-1 pc mutation maps to 
a-helix 2 of the Pit-1 POUs domain (Assa-Munt et al. 
1993). Although it is unknown how Pit-1 activates tran- 
scription, the existence of these similar mutations in a 
human and bacteriophage protein suggests that func- 
tional as well as structural similarities are shared by 
these distantly related proteins. 
POUH-domain structure 
The conserved association of POUs domains with 
POUH-type homeo domains uggests that there may be 
some advantage for the POUH domain to be part of a 
POU domain. As shown in Figure 3, the sequences of the 
DNA-recognition helix (or3) in POU H domains are very 
similar to one another. For example, in contrast to other 
homeo domains, in all POUH domains, the ninth residue 
of the DNA-recognition helix is a cysteine. This position 
of the DNA-recognition helix is used by other types of 
homeo domains to discriminate among different DNA- 
binding sites (Hanes and Brent 1989; Treisman et al. 
1989). The POUH-domain cysteine residue might have 
been conserved at this position because it provides for a 
unique homeo-domain structure or contacts a DNA se- 
quence shared by POU protein-binding sites. But, para- 
doxically, the Oct-1 POUH domain is essentially identi- 
cal in backbone structure to other homeo domains and 
the conserved cysteine contacts a region that is variable 
even among Oct-1 binding sites--the two residues im- 
mediately 3' of the octamer sequence ATGCAAAT 
(Klemm et al. 1994). As we propose below, the answer to 
this paradox may involve the difference between a ho- 
meo domain that binds independently to DNA and one 
like the POUH domain that binds DNA together with a 
second DNA-binding domain. 
Unlike independent homeo domains where the DNA- 
binding specificity of the protein is largely conferred by 
the homeo domain, in POU proteins, both the POUH 
domain and the POUs domain confer DNA-binding spec- 
ificity (Ingraham et al. 1990; Aurora and Herr 1992; Ver- 
rijzer et al. 1992; Pomerantz and Sharp 1994). Such an 
arrangement could result in very strict overall DNA- 
binding specificity if each domain were already highly 
specific on its own. Perhaps, in POUI-I-type homeo do- 
mains, the DNA-recognition-helix cysteine residue has 
been conserved precisely because it confers little DNA- 
binding specificity, thus promoting more relaxed DNA 
sequence recognition by POU domains. Indeed, unlike 
the corresponding glutamine residues in the Drosophila 
Antennapedia and engrailed borneo domains (Kissinger 
et al. 1990; Otting et al. 1990), the Oct-1 POUH-domain 
cysteine does not form a hydrogen bond with the DNA 
when the POU domain is bound to the histone H2B oc- 
tamer site (Klemm et al. 1994); instead, it forms a hy- 
drogen bond with a main-chain homeo-domain residue 
while forming van der Waals contacts with the two thy- 
midines flanking the histone H2B octamer sequence. We 
imagine that, on DNA sites that provide a hydrogen 
bond acceptor, the cysteine could swing out to form a 
hydrogen bond with the DNA, adding flexibility in the 
way the POUH domain recognizes DNA. 
POU-domain linker 
The h repressor DNA-binding domain binds DNA as a 
dimer, and there is an additional a-helix responsible for 
stabilizing the dimer on the DNA (see Pabo and Sauer 
1992). Although the POU domain is a single molecule, it 
can be thought o bind DNA as a dimer--a fused hetero- 
dimer--in which the dimer subunits, the POUs and 
POUH domains, are stabilized through covalent attach- 
ment by a linker that takes the place of the h repressor 
dimerization helices. 
Perhaps the most interesting feature of the POU do- 
main-octamer site cocrystal structure is that, from be- 
ginning to end, the linker connecting the POUs and 
POUH subdomains i not visible in the electron density 
map (Klemm et al. 1994). Thus, the Oct-1 linker is ap- 
parently not a rigid structure. This finding explains why, 
as shown in Figure 3, the length and sequence of the 
linker can vary greatly among POU proteins. It also pro- 
vides a mechanism for flexibility in how the POU do- 
main interacts with DNA, because there might not be a 
strict arrangement of the POUs and POUH domains on 
the DNA. 
Even though the linker is flexible, it can influence the 
DNA-binding specificity of the POU domain and in 
some instances is highly related between POU domains 
of distantly related species. The influence on DNA bind- 
ing has been observed with chimeras of the Oct-1 and 
Pit-1 POU domains (Aurora and Herr 1992); it is not 
known, however, whether the effect on DNA-binding 
specificity observed was because of the difference in the 
sequence or in the length (24 vs. 15 amino acids) of the 
Oct-1 and Pit-1 linkers (see Fig. 3). 
A high level of linker sequence similarity is seen when 
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the Drosophila drifter and mammalian Brn-2 POU-do- 
main linkers are compared; these proteins contain nearly 
identical 17-amino-acid linker sequences: 
Dm drifter STTGSPTS IDKIAAQGR 
Mu Bm-2 S_S SGSPTS IDKIAAQGR 
Two other related linker segments are found in the 
mammalian SCIP and nematode CEH-6 proteins (see Fig. 
3). Such high levels of sequence similarity suggest that, 
although the linker is probably flexible, at least in some 
cases, there are important structural features to the 
linker. These four proteins are all expressed in neural 
cells (He et al. 1989; Monuki et al. 1989; Johnson and 
Hirsh 1990; Hara et al. 1992; T. B/irglin and G. Ruvkun, 
pers. comm.). Thus, this particular linker may be con- 
served because it adopts a specific conformation that is 
important to these neural POU-domain proteins, such as 
one that provides for neural cell-specific interactions 
with DNA or with coregulatory proteins. 
Functional POUs and POUH interdependence without 
direct protein-protein contacts 
In some cases, either as a result of alternative mRNA 
splicing (Day and Day 1994; Takeda et al. 1994) or mu- 
tagenesis (Greenstein et al. 1994), the POUs and POUH 
domains can display activity in vivo on their own. Nev- 
ertheless, the POUs and POUH domains have coevolved, 
and they generally cooperate in binding DNA and acti- 
vating transcription. In binding DNA, they can also in- 
fluence one another's DNA-binding specificity (Aurora 
and Herr 1992; Verrijzer et al. 1992). 
Such coevolution and intersubunit influence could 
have been explained by direct contacts between the two 
DNA-bound POU subdomains that are critical for their 
function. It was therefore unexpected that the structure 
of the Oct-1 POU domain bound to an octamer site 
showed no evident contact between th  POUs and POUH 
domains (Klemm et al. 1994; see Fig. 2). One hypothesis 
is that the POUs and POUH domains influence one an- 
other via indirect interactions through theDNA. What- 
ever the case, however, the lack of intersubunit contact 
emphasizes the importance of the linker segment for al- 
lowing these two DNA-binding modules to function in- 
terdependently as a unit. 
As described below, the apparent structural f exibility 
of the linker allows the POUs and POUH domains to 
adopt diverse arrangements on the DNA, providing ver- 
satility in how POU proteins bind DNA and interact 
with other regulatory proteins. Before discussing such 
versatility, however, we first describe how POU proteins 
can share overlapping DNA-binding site preferences. 
Overlapping binding-site specificities hared by 
POU-domain proteins 
Consistent with their conserved structure, POU-domain 
proteins bind to related DNA sequences. Nonetheless, 
most POU-domain proteins have diverged sufficiently 
that their precise DNA-binding site preferences differ. 
Oct-1 and Oct-2 are an exception; they carry very closely 
related POU domains (see Fig. 3}, and they both recog- 
nize the same precise octamer sequence found in many 
promoters in addition to the histone H2B promoter 
(Falkner and Zachau 1984; Parslow et al. 1984; Landolfi 
et al. 1986; Singh et al. 1986; Staudt et al. 1986). Other 
POU proteins also recognize the octamer sequence, but 
in contrast o Oct-1 and Oct-2, the octamer sequence is 
usually not their highest affinity binding site. For exam- 
ple, although Pit-1 can bind the octamer sequence, this 
sequence is neither its preferred binding site in vitro nor 
its preferred cis-regulatory site in vivo (Elshohz et al. 
1990; Aurora and Herr 1992). 
Oct-1 and Oct-2 were named "Oct" factors because of 
the octamer sequence to which they bind. In some cases, 
other POU proteins have also been named Oct factors 
because they were also first identified by their ability to 
bind the octamer sequence [e.g., Oct-3/4 (Lenardo et al. 
1989; Sch61er et al. 1989), Oct-6 (SCIP)(Sch61er et al. 
1989), and N-Oct-3 (Brn-2)(Schreiber t al. 1990)]. In 
these latter cases, however, this nomenclature may be 
misleading because, as in the case of Pit-l, the octamer 
sequence may not be their preferred binding site. Such is 
the case for Brn-2, the mouse homolog of the human 
N-Oct-3 protein, which prefers ites such as those listed 
in Figure 6C, below (Li et al. 1993). 
Diverse DNA sequence recognition by POU-domain 
proteins 
A characteristic of POU-domain proteins is their ability 
to recognize diverse sets of DNA sequences. Figure 6 
illustrates the diversity of sites bound by the Oct-i, Pit- 
1, and Bin-2 POU-domain proteins. In addition to the 
high-affinity octamer sequence found in many different 
promoters, Oct-1 and Oct-2 recognize, although with 
lower affinity, important cis-regulatory sites with little 
octamer motif similarity (Baumruker et al. 1988; apRhys 
et al. 1989; Kemler et al. 1989; Bendall et al. 1993). Fig- 
ure 6A shows examples of two such types of sites: 
(OCTA-)TAATGARAT sites, which are important for 
herpes simplex virus gene regulation (see below) and 
heptamer (Hept) sites, which are involved in immuno- 
globulin gene expression (Kemler et al. 1989). 
Pit-1 binds a complex set of regulatory sites in the 
prolactin and growth hormone promoters (Bodner and 
Karin 1987; Nelson et al. 1988). Figure 6B shows the 
sequences of five high-affinity Pit-l-binding sites from 
these two promoters. Although a core Pit-1-binding site 
consensus sequence bearing similarity to an octamer se- 
quence has been derived (see Fig. 6B), unlike Oct-1 and 
Oct-2, Pit-1 does not bind a highly conserved consensus 
sequence (Nelson et al. 1988). 
The ability of POU proteins uch as Oct-1 and Pit-1 to 
recognize diverse DNA sequences i an important aspect 
of their transcriptional regulatory properties. It permits 
variation in the incorporation of POU-domain protein- 
binding sites into promoters. In addition, the binding of 
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A. Oct-I  Binding Sites 
Qctamer 
H2B CTTATGCAAATGAG 
Ad2 ori AATATGATAATGAG 
TAATGARAT 
(OCTA+)TAAT ATGCTAATGATATTC 
(OCTA-)TAAT GCGGTAATGAGATAC 
Other 
Hept/Octa CTCATGAATATGCAAAT 
B. Pit- i  B inding Sites 
rGHI 
p3D 
rGH2 
pIP 
plD 
Consensus 
GCCATGAATAAATGATAGG 
ATGGTGAATAATAATGAAG 
C TGATGGATAATTTAGAAG 
TTCATGAATATATATATAA 
AAAATGCATTTTTTAATGC 
ATGNATAWWT 
C. Brn-2 Binding Sites 
C RH- I I TGCATAAATAATAGGC 
CRH- IV GC GAT- - - TAATAAGC 
CRH-V CACTTGGATAATAAGC 
Figure 6. DNA-binding sites of three POU-domain proteins, 
Oct-l, Pit-l, and Bin-2. (A) The Oct-l-binding sites are grouped 
according to similarity. In each case the relevant sequences ar  
underlined except for the overlapping octamer sequence in the 
{OCTA+)TAATGARAT site. (B) The Pit-l-binding sites and 
definition of a core consensus {Consensus) sequence {underlined 
and shown at the bottom) originate from Nelson et al. (1988). 
(N) Any base; (W) A or T. (C) The natural Brn-2-binding sites 
originate from Li et al. (1993) and are found in the corticotropin- 
releasing hormone (CRH) promoter. The POUs and POUH do- 
main "half" sites are underlined; hyphens denote gaps placed in 
the sequence forbetter sequence alignment. 
POU proteins to different DNA sequences provides se- 
lectivity in their association with regulatory cofactors. 
Mechanisms for flexible DNA sequence recognition 
by POU domains 
Studies of Oct-1 and Brn-2 have revealed two mecha- 
nisms by which POU domain proteins can recognize di- 
verse sequences (Li et al. 1993; Cleary and Herr 1995): 
flexible amino acid-base interactions and flexible posi- 
tioning of the POUs and POUR domains with respect o 
one another on the DNA. 
The first mechanism involves an invariant arginine 
residue, R49, in the Oct-1 POUs DNA-recognition helix 
(residue 49 in Fig. 3). Figure 5 shows the position of this 
residue relative to the position of the two glutamine res- 
idues that are shared between POU s domains and the 
bacteriophage k and 434 repressor and 434 Cro proteins. 
In contrast o the glutamine residue Q44, which makes 
The POU domain 
highly selective contacts with an adenine in the DNA, 
R49 tolerates changes in its base contacts in the octamer 
site. This residue contacts the third and fourth base pairs 
of the ATGCAAAT octamer sequence [Klemm et al. 
1994) but makes little distinction between the octamer 
sequence and the variant sequence ATTTAAAT, even 
though alanine substitution of this residue shows that it 
is very important for binding to both sites {Cleary and 
Herr 1995). These results suggest hat R49 is able to 
modify its interactions with the DNA to permit recog- 
nition of divergent octamer sequences. An example of a 
natural Oct-l-binding site where this type of divergent 
sequence recognition may be important is in the adeno- 
virus 2 origin of replication (Ad2 ori), where the fourth 
position differs from the consensus (see Fig. 6A)._ 
Figure 7 illustrates the second more drastic mecha- 
nism for flexible DNA sequence recognition; here, the 
orientations and positions of the POUs and POUH do- 
mains with respect to one another can differ on the 
DNA. In the first example (Fig. 7A), in comparison to the 
Oct-1 POU domain bound to an octamer sequence (top), 
combined mutagenesis of the Brn-2 POUs domain and 
Brn-2-binding sites suggests that the orientation of the 
Brn-2 POUs domain is turned around by 180 ~ when 
bound to the variant octamer sequence GCATTAAT 
(bottom), in which the high-affinity POUs binding site 
ATGC is inverted (underlined; Li et al. 1993). Bm-2 (N- 
Oct-3) can also bind an octamer sequence (Schreiber et 
al. 1990; Li et al. 1993). On an octamer site, the Brn-2 
POUs domain may switch its orientation to adopt he 
Oct-1 POU domain conformation (Li et al. 1993). 
In the second example (Fig. 7B), the inverted Bm-2 
POUs domain binds effectively to sites with different 
spacing between the POUs and POUH domain-binding 
sites (Li et al. 1993). This latter mechanism explains the 
ability of Brn-2 to recognize the sites shown in Figure 
6C, in which the spacing between the POUs and POUR 
domain-binding sites can vary (see underlined se- 
quences). Another brain POU protein, Brn-3.0, has a dif- 
ferent preference for the spacing between the POUs and 
POUH domain-binding sites, and this difference is dic- 
tated by a few amino acid differences in the amino-ter- 
minal region of the POU R domain (Li et al. i993). These 
results elegantly demonstrate one mechanism by which 
different POU-domain proteins (i.e., Brn-2 and Brn-3.0) 
can display different DNA-binding site preferences. 
Studies of Oct-1 binding to sites that respond to the 
herpes simplex virus (HSV) activator VP16 suggest a 
third rearrangement of the two POU DNA-binding do- 
mains on DNA (Fig. 7C). After HSV infection, VP16 ac- 
tivates HSV immediate-early (IE) transcription by form- 
ing a muhiprotein VP16-induced complex with Oct-1 on 
sites that conform to a sequence motif called TA_ATGA- 
RAT, where R designates a purine. TAATGARAT sites 
fall into two classes: (OCTA + ) and (OCTA-). As shown 
in Figure 6A, (OCTA+)TAATGARAT sites contain an 
overlapping octamer sequence (oVerlined), which serves 
as a binding site for Oct-1 (Kristie et al. 1989), whereas 
(OCTA-)TAATGARAT sites bear little octamer simi- 
larity but still bind Oct-l, albeit with reduced affinity 
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Figure 7. Different arrangements of the 
Oct-1 and Bm-2 POUs (red) and POUH 
(blue) domains on DNA. POU s and POUH 
domain-binding sites are underlined and 
overlined, respectively. Arrows indicate 
the orientation ofthe POU s and POUH do- 
mains based on the direction of the turn 
between u-helices 1 and 2 in each struc- 
ture (i.e., pointing up in Fig. 4). (A) Oct-1 
bound to an octamer sequence (top) and 
Brn-2 bound to a consensus Brn-2 DNA- 
binding site with a spacing of zero be- 
tween half sites {bottom) are shown. (B) 
Brn-2 bound to consensus ites with a 
spacing of 0 (top) or 2 (bottom)bp between 
POUs and POU H domain-binding sites. 
(N) Any base. (C) Oct-1 bound to octamer 
(top) and (OCTA-)TAATGARAT {bot- 
tom) sites. The broken underline and dou- 
ble-headed arrow indicate the ambiguity 
in orientation of the POUs domain over 
the GARAT (GAGATAC) element. 
(Baumruker et al. 1988; apRhys et al. 1989). On the 
(OCTA-)TAATGARAT site (Fig. 7C, bottom), com- 
bined POU domain and binding site mutagenesis exper- 
iments suggest hat the POUs domain is positioned over 
the GARAT element o the side opposite of the POU H 
domain from where it is located on an octamer site (Fig. 
7C, top) (Cleary and Herr 1995). The orientation of the 
POUs domain on the (OCTA-)TAATGARAT site, how- 
ever, is not known (hence the double-headed arrow in 
the Fig. 7C); indeed, the POUs domain may be able to 
bind in either orientation. 
These results suggest that on VP16-responsive 
(OCTA +) and (OCTA-) TAATGARAT sites the Oct-1 
POUs and POU H domains are positioned ifferently. On 
an (OCTA + )TAATGARAT site, however, the POU s do- 
main may be able to bind to either the 5' ATGC segment 
of the octamer sequence as in Figure 7C, top, or to the 3' 
GARAT segment as in Figure 7C, bottom. This flexibil- 
ity may explain the conformational lteration in Oct-1 
binding observed by Walker et al. (1994) on 
(OCTA +)TAATGARAT sites containing wild-type ver- 
sus mutated GARAT segments. They found that, when 
the 3' GARAT segment is mutated, the Oct-1 POU do- 
main binds the 5' ATGC octamer segment more effec- 
tively. The models for Oct-1 binding to the octamer and 
TAATGARAT sequences in Figure 7C suggest hat the 
interaction of the Oct-1 POUs domain with the 5' ATGC 
portion of the octamer sequence should be stabilized by 
mutations in the secondary 3' GARAT POUs-domain- 
binding site. 
The three different modes of flexible POU domain in- 
teraction with DNA illustrated in Figure 7 appear to 
arise from the unique property of POU domains: that 
they are made up of the tethering of two structurally 
independent DNA-binding domains through a flexible 
linker. It should be cautioned, however, that all of the 
studies that have suggested flexible interactions with 
DNA have been indirect, generally involving analyses of 
the differential effects of combined POU-domain and 
binding-site mutations on POU-domain-DNA binding; 
direct studies, such as protein-DNA cross-linking or 
X-ray crystallography, will be necessary to establish the 
veracity of these conclusions. 
Modulation of POU-domain DNA-binding specificity 
by post-translational modification 
The DNA-binding activity of POU domains can be in- 
fluenced by post-translational modification. Phosphory- 
lation of homologous ites in the Oct-1 and Pit-1 POU H 
domains by protein kinase A can inhibit DNA binding 
(Kapiloff et al. 1991; Segil et al. 1991). In Oct-l, such 
modification occurs during mitosis and inhibits binding 
to the histone H2B octamer site (Segil et al. 1991). In 
Pit-l, by comparing the binding of nonphosphorylated 
and phosphorylated Pit-1 to a series of different Pit-l- 
binding sites, Kapiloff et al. (1991) showed that protein 
kinase A phosphorylation modulates its DNA-binding 
activity, having little if any effect on binding to some 
sites and drastically reducing binding to other sites. 
Thus, phosphorylation provides an elegant mechanism 
to modulate POU-domain DNA-binding activity in re- 
sponse to cellular changes uch as during the cell cycle 
or in response to extracellular signals. 
Cooperative binding among POU proteins 
to cis-regulatory sites 
One of the distinctive modes of DNA-binding versatility 
exhibited by POU proteins is their ability to bind DNA 
either as a monomer or cooperatively as a homo- or het- 
ero-POU-domain dimer. Oct-1 and Oct-2 bind cis-regu- 
latory sites effectively as monomers, whereas Pit-1 
forms highly cooperative homodimeric complexes on its 
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regulatory sites (Ingraham et al. 1990). Pit-1 and Oct-1 
can also form a heterodimeric complex on a Pit-1-bind- 
ing site in the prolactin promoter (site p lP in Fig. 6B) 
(Voss et al. 1991). This heterodimeric complex displays 
somewhat higher levels of transcriptional activation 
than either protein alone, indicating transcriptional c- 
tivation synergy between these two POU proteins (Voss 
et al. 1991}. 
Oct-1 and Oct-2 form cooperative homo- or het- 
erodimers on a regulatory site in immunoglobul in 
heavy-chain {IgH)promoters (Kemler et al. 1989; LeBo- 
witz et al. 1989; Poellinger et al. 1989). This site contains 
two adjacent Oct-l- or Oct-2-binding sites, a high-affin- 
ity octamer sequence, and the much lower affinity hep- 
tamer sequence (see the Hept/Octa site in Fig. 6A). Al- 
though of low affinity for Oct-1 or Oct-2 on its own, in 
cooperation with the octamer sequence, the heptamer 
sequence can contribute to activation of transcription in 
vivo (Kemler et al. 1989). 
The arrangement of the POUs and POUH domains in 
these natural dimeric complexes i not known. On a syn- 
thetic pair of inverted octamer sites, cooperativity is 
probably achieved through interactions between adja- 
cent POU s domains (LeBowitz et al. 1989). It is possible, 
however, that on the natural Pit-1 and Oct-1/Oct-2 sites 
the two POU domains in the dimer adopt different con- 
formations, such as the two arrangements shown in Fig- 
ure 7C. Indeed, Pit-1 binds the two sites hown in Figure 
7C, the octamer and (OCTA-)TAATGARAT sites, with 
near equal effectiveness a a monomer (Aurora and Herr 
1992). On its more complex regulatory sites, the Pit-1 
POU domain might bind as a combination of these two 
arrangements, thus generating a homodimer that is 
structurally heterodimeric. Understanding how Pit-1 
binds to its natural sites will probably require elucida- 
tion of the structure of the Pit-1 POU domain bound to 
such a site. 
POU-domain  interact ions w i th  hetero logous proteins 
In addition to binding DNA together with other family 
members, POU proteins display considerable versatility 
in their interaction with heterologous non-POU pro- 
teins. Table 1 shows a summary of the interactions with 
heterologous proteins that have been described on differ- 
ent promoters and, in one case, on a viral origin of rep- 
lication. The POU proteins Oct-1 and Oct-2 have also 
been shown to interact with a heterologous protein, the 
TATA box-binding protein TBP, off of DNA {Zwilling et 
al. 1994); however, because this interaction is not depen- 
dent on cis-regulatory sites, it is difficult to demonstrate 
that it is used to regulate transcription by these proteins. 
In Table 1, the proteins that associate with the POU 
proteins have been divided into three different ypes of 
transcription factors--activator, coregulator, and basal 
transcription factor--and a DNA replication factor, the 
adenovirus DNA polymerase. The basal transcription 
factor is the proximal sequence lement (PSE)-binding 
factor PTF (Murphy et al. 1992; Yoon et al. 1995), which 
is probably related but not identical to the TBP-contain- 
ing basal complex called SNAPc (Sadowski et al. 1993; 
Henry et al. 1995). The Oct-1 and Oct-2 POU domains 
bind cooperatively with PTF and SNAPr demonstrating 
a direct cooperative interaction between a site-specific 
DNA-binding domain and a basal transcription factor 
complex (Murphy et al. 1992; V. Mittal, M. Cleary, W. 
Herr, and N. Hemandez, unpubl.). 
Members of the activator and coregulator classes are 
differentiated by their inherent ability to bind cis-regu- 
latory sites on their own. The mammal ian  activators 
Spl, Ap-1, and progesterone (PR) and glucocorticoid (GR) 
receptors and the Caenorhabditis elegans activator 
MEC-3 bind certain regulatory DNA sites well on their 
own but also cooperate with a POU-domain protein in 
binding to sites as a heteromeric complex. In this man- 
Table 1. Factors that associate with POU-domain proteins on cis-regulatory sites 
Interacting POU domain 
POU protein factor Type responsible Comment 
Oct- 1 Sp 1 activator N.D. 
Oct- 1 Ap- 1 activator N.D. 
Oct- 1 PR/GR activator N.D. 
UNC-86 MEC-3 activator yes 
Oct- 1 VP 16 coregulator yes {POUH) 
Oct -3/4 E 1A coregulator N.D. 
Oct- 1 and Oct-2 OCA-B/OBF- 1/Bob 1 coregulator yes 
Oct- 1 PTF (SNAPc) basal factor yes 
Oct-1 Ad DNA pol replication factor yes (POUH) 
zinc finger protein 
bZIP protein 
steroid receptors 
homeo-domain protein 
herpesvirus protein 
adenovirus protein 
B-cell-specific protein 
snRNA promoter factor 
adenovirus protein 
References for each interaction: Oct- 1 with Sp 1 (Janson and Pettersson 1990); Oct- 1 with Ap- 1 (Ullman et al. 1991, 1993); Oct- 1 with 
PR and GR (Brfiggemeier t al. 1991); UNC-86 with MEC-3 (Xue et al. 1993); Oct-1 with VP16 {see text}; Oct-3/4 with EIA {Sch61er 
et al. 1991); Oct-1 and Oct-2 with OCA-B/OBF-1/Bobl [Luo et al. 1992; Gstaiger et al. 1995; Luo and Roeder 1995; Strubin et al. 19951; 
Oct-1 with PTF (SNAPc) (Murphy et al. 1992; V. Mittal, M. Clear], W. Herr, and N. Hemandez, unpubl.); Oct-1 with Ad DNA pol 
{Coenjaerts et al. 1994). 
Abbreviations: {PR) Progesterone r ceptor; (GR) glucocorticoid receptor; [N.D.) not determined. 
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ner, Oct-1 interacts with (1) the TFIIIA zinc finger pro- 
tein Spl in small nuclear RNA (snRNA)-type transcrip- 
tion (Janson and Pettersson 1990), (2) bZIP proteins in 
the Ap-1 {OAP) transcription complex in binding to the 
interleukin-2 promoter {Ullman et al. 1991, 1993), and 
(3) the steroid receptors PR and GR in binding to the 
routine mammary tumor virus (MMTV) promoter 
(Briiggemeier et al. 1991). Furthermore, UNC-86 cooper- 
ates with the homeo-domain protein MEC-3 in binding 
to the mec-3 promoter (Xue et al. 1993). 
The coregulators listed in Table 1 do not bind DNA 
effectively on their own but can do so in association with 
a POU-domain protein and can have profound effects on 
the regulatory properties of POU-domain proteins. These 
coregulators include two viral proteins, the HSV virion 
protein VP16 and the adenovirus protein E1A, and a 
B-cell coregulator variously termed OCA-B, OBF-1, and 
Bob l. The best understood of these coregulator-POU- 
domain interactions i  the selective association of VP16 
with the Oct-1 but not the Oct-2 POU domain in a VPl6- 
induced complex formed after HSV infection on IE pro- 
moters. 
The VPl6-induced complex 
Figure 8 shows a diagram of the VP16-induced complex; 
its protein components include VP16, Oct-l, and a sec- 
ond host cell factor that we refer to as HCF. VP16, also 
referred to as Vmw65 and a-TIF, is a multifunctional 
protein of 490 amino acids that serves as both an essen- 
tial structural component of the HSV virion and an ac- 
tivator of HSV IE gene transcription (for reviews and ref- 
erences, see Thompson and McKnight 1992; O'Hare 
1993). It contains two functional regions: a potent 80- 
amino-acid carboxy-terminal transcriptional activation 
domain and a 400-amino-acid amino-terminal region, 
which negotiates assembly of the VP16-induced com- 
plex. 
After HSV infection, VP16 first forms a heteromeric 
complex with HCF (Katan et al. 1990; Kristie and Sharp 
1990; Xiao and Capone 1990; Stern and Herr 1991). HCF, 
Figure 8. Diagram of the VP16-induced complex. The box in- 
dicates the TAATGARAT DNA element, the hatched ovals in- 
dicate the Oct-1 POU s and POUH domains, and the four hori- 
zontal bars indicate the VP16 transcriptional ctivation do- 
main. The broken border between VP16 and HCF denotes that 
these two proteins remain associated off the DNA. 
which has also been referred to as C1, VCAF, and CFF, is 
a large protein, which, after synthesis, is cleaved at one 
or more centrally located sites into heterogeneous 
amino- and carboxy-terminal halves that remain nonco- 
valently associated with one another {Wilson et al. 1993; 
Kristie et al. 1995). The cellular function of HCF is un- 
known, but its binding to VP16 promotes association of 
VP16 with Oct-1 on the target of VP16 activation, the 
(OCTA+) - and (OCTA-)TAATGARAT sites (see Fig. 
6A) found in HSV IE promoters (Gerster and Roeder 
1988; Kristie et al. 1989). 
In the VP16-induced complex, VP16 apparently con- 
tacts each of the other components of the complex, Oct- 
1, HCF, and DNA, and mutations in VP16 can selec- 
tively affect each of these interactions (Stem and Herr 
1991; Walker et al. 1994; J.-S. Lai and W. Herr, unpubl.). 
Although it is not universally accepted (Walker et al. 
1994), a number of studies indicate that VP16 binds to 
DNA in the complex (Kristie and Sharp 1990; Stem and 
Herr 1991; C. Huang, J.-S. Lai, and W. Herr, unpubl.). 
The influence of Oct-1 on VP16-induced complex for- 
mation differs depending on the nature of the Oct-l- 
binding site (Cleary and Herr 1995). These differences are 
the result of the POUs domain. On an 
(OCTA + )TAATGARAT site, the effect of mutations in 
the Oct-1 POU s domain on VP16-induced complex for- 
mation parallels their influence on DNA binding itself. 
On an (OCTA-)TAATGARAT site, however, where the 
POUs domain may interact with a GARAT element also 
bound by VP16, the effect of mutations in the POUs 
domain on formation of a VP16-induced complex does 
not always correspond to their effect on DNA binding to 
this site alone but, instead, appear to selectively affect 
VP 16-induced complex formation. These different activ- 
ities indicate that, by virtue of its ability to adopt differ- 
ent conformations on DNA, the POU domain can differ- 
entially influence association with a coregulatory pro- 
tein on different sites. 
VP16 associates well with Oct-1 but not Oct-2 by dis- 
criminating between the homeo domains of these two 
proteins (Stem et al. 1989). The Oct-1 and Oct-2 homeo 
domains differ at seven positions on the exposed surface 
of the DNA-bound homeo domain: three positions in 
each of a-helices 1 and 2 and one position in the turn 
between oL-helices 2 and 3 (see Fig. 3), all of which are 
accessible when these proteins are bound to DNA. Al- 
though several residues in the Oct-1 homeo domain are 
important for association with VP16 (Pomerantz et al. 
1992; Walker et al. 1994), one difference between the 
Oct-1 and Oct-2 homeo domains, a glutamic acid residue 
in Oct-1 for an alanine residue in Oct-2 at the top of 
(x-helix 1 (position 22; see Fig. 3), is the primary deter- 
minant for selective association of Oct-1 and not Oct-2 
with VP16 (Lai et al. 1992; Pomerantz et al. 1992). Ex- 
change of this amino acid from Oct-1 into Oct-2 trans- 
fers the selective VP16 response of Oct-1 to Oct-2 (Lai et 
al. 1992). Thus, a single amino acid difference between 
two POU domains can have a large influence on the re- 
sponse to a coregulator, through its effects on coassoci- 
ation. 
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The adenovirus DNA polymerase also interacts with 
the Oct-1 homeo domain, but different residues are im- 
portant for VP16 and adenovirus DNA polymerase asso- 
ciation, demonstrating that different surfaces of the 
Oct-1 homeo domain can be responsible for interaction 
with heterologous proteins {Coenjaerts et al. 1994). 
The VPl6-induced complex provides a mechanism 
for selectivity in transcriptional regulation by proteins 
that bind the same DNA sequence 
Although Oct-1 and Oct-2 share very similar POU do- 
mains (see Fig. 3) and both recognize the octamer se- 
quence with high affinity, these two POU proteins dis- 
play different transcriptional regulatory properties and 
thus have served as a paradigm for understanding how 
proteins with the same DNA-binding specificity can dif- 
ferentially activate transcription (for review, see Herr 
1992). Oct-1 is expressed in many if not all cell types and 
is implicated in regulating synthesis of proteins and 
RNAs that are required for cell growth and proliferation, 
such as histone H2B, which is required for chromatin 
formation, and snRNAs, which are required for RNA 
processing. Oct-2 expression is restricted to certain cell 
types, including B cells and neural cells, and is impli- 
cated in the regulation of immunoglobulin gene tran- 
scription. 
Figure 9 illustrates how the selective association of 
VP16 with Oct-1 can result in differential regulation of 
transcription by Oct-1 and Oct-2. As illustrated in Figure 
9A, on high-affinity Oct-l- and Oct-2-binding sites (i.e., 
octamer sites), Oct-1 and Oct-2 preferentially activate 
different ypes of RNA polymerase II promoters: Oct-1 
activates nRNA promoters preferentially, and Oct-2 ac- 
tivates mRNA-type promoters preferentially. These dif- 
ferent activities result from the different properties of 
"promoter-selective" activation domains that lie outside 
of the POU domains of these two proteins (Tanaka et al. 
1992). Thus, promoter-selective activation domains pro- 
vide one mechanism by which activators that share the 
same DNA-binding specificity can selectively activate 
different promoters. 
Both Oct-1 and Oct-2, however, bind the 
(OCTA-)TAATGARAT site with low affinity in vitro 
(Fig. 9B) and do not activate either snRNA or mRNA 
promoters containing such a site effectively in vivo 
(Cleary et al. 1993). Oct-l, however, is stabilized on the 
{OCTA-)TAATGARAT site by its association with 
VP16 (see Fig. 9C) and can activate transcription of an 
mRNA-type promoter effectively via the potent VP16 
activation domain; Oct-2 still fails to activate transcrip- 
tion because it does not associate with VP16 (Cleary et 
al. 1993). Thus, by selective association with the Oct-1 
POU domain, VP16 influences Oct-1 in two ways: It 
brings Oct-1 to a new regulatory site through corecruit- 
ment and provides a new activation domain that acti- 
vates mRNA-type promoters very well. These two ef- 
fects of VP16 on Oct-1 provide a second mechanism by 
which activators with the same DNA-binding specific- 
Figure 9. Differential regulation of transcription by Oct-1 and 
Oct-2 mediated by selective association ofVP16 with Oct-1. (A) 
Activation of an snRNA promoter by Oct-1 and an mRNA pro- 
moter by Oct-2 from high-affinity octamer sites. (B) Inactivity of 
Oct-1 and Oct-2 with promoters containing the low-affinity 
(OCTA-)TAATGARAT site. {C) Activation of an mRNA pro- 
moter by Oct-1 but not Oct-2 through selective corecmitment 
onto an {OCTA-)TAATGARAT site with VP16 and HCF. The 
diagram of the Oct-l/VP16 complex is as described n Fig. 8. 
ity, in this case Oct-1 and Oct-2, can differentially acti- 
vate transcription. 
A B-cell-specific oregulator provides a mechanism 
[or B-cell-specific activation of promoters by Oct.1 
Much in the way VP16 allows Oct-1 to activate mRNA 
promoters in HSV-infected cells, the B-cell-specific fac- 
tor OCA-B {see Table 1) permits Oct-1 to activate mRNA 
promoters {i.e., immunoglobulin promoters) in B cells 
{Pierani et al. 1990; Luo et al. 1992; Gstaiger et al. 1995; 
Luo and Roeder 1995; Strubin et al. 1995). Unlike VP16, 
OCA-B associates with both the Oct-1 and Oct-2 POU 
domains but not other POU domains. OCA-B enhances 
the ability of Oct-1 to activate immunoglobulin promot- 
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ers, apparently by providing an mRNA-type activation 
domain (Luo et al. 1992; Gstaiger et al. 1995; Luo and 
Roeder 1995; Strubin et al. 1995}. Thus, like VP16, 
OCA-B alters the promoter-selective activation domain 
properties of Oct-1 through association with the POU 
domain. This Oct-l-modifying activity probably ex- 
plains why loss of Oct-2 can be tolerated in B cells with- 
out complete loss of octamer-dependent B-cell-specific 
mRNA gene expression (Corcoran et al. 1993; Feldhaus 
et al. 1993; Pfisterer et al. 1994). 
A highly conserved DNA-binding structure 
confers transcriptional regulatory selectivity 
One of the surprises in the analysis of POU protein in- 
teraction with coregulators is that interaction with a 
highly conserved region, the POU domain itself, gener- 
ates transcriptional regulatory selectivity. We originally 
imagined that regions of greater sequence difference, for 
example, sequences lying outside of the POU domain, 
would be the likely targets for selective interactions be- 
tween POU proteins and coregulators. Subsequently, 
however, it became evident that only very subtle differ- 
ences, as subtle as a single amino acid difference as in the 
case of the differential interaction of Oct-1 and Oct-2 
with VP16, can provide POU-protein-coregulator selec- 
tivity. This finding may explain why the POU domain is 
an attractive target for coregulator interactions: It is suf- 
ficiently flexible to provide the very small changes re- 
quired for selective interaction, and meanwhile, as a re- 
sult of its function in DNA binding, it is a highly con- 
served structure that forms a solid foundation on which 
a coregulator can form protein-protein contacts. 
Versatile transcriptional regulation by a two-in-one 
DNA-binding domain 
In conclusion, the POU domain illustrates how the 
structure of a DNA-binding domain can profoundly in- 
fluence the activity of transcriptional regulators. The 
POU domain represents a fused heterodimer in which 
two different types of structurally independent HTH- 
containing DNA-binding domains are brought together 
to form a single DNA-binding unit. The flexibility of the 
association of the two domains, provided by a linker 
with little apparent structure, results in versatility in its 
interactions with DNA and other proteins in transcrip- 
tional regulation. 
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